Case Study: a global pharmaceutical sponsor achieves enterprise-wide RBQM adoption with Axtria

Global Pharmaceutical Sponsor improves RBQM risk response times with Axtria

The global pharmaceutical sponsor faced a fragmented and reactive approach to clinical trial oversight, with risk management tools and expertise siloed across different therapeutic areas. This gap between regulatory intent and operational reality created a reliance on external vendors and left internal teams unable to act on the data from their dashboards. They partnered with Axtria to address this challenge.

Axtria implemented a three-phase solution, designing a unified RBQM framework, taking over continuous centralized monitoring for the entire portfolio, and building internal capability through training. This partnership transformed the client's operation into a proactive, self-sustaining quality management function. Axtria's work significantly improved risk detection and response times and reduced the client's long-term operational dependency while maintaining consistent standards.